BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 29165639)

  • 21. Global gene expression analysis reveals reduced abundance of putative microRNA targets in human prostate tumours.
    Sun R; Fu X; Li Y; Xie Y; Mao Y
    BMC Genomics; 2009 Feb; 10():93. PubMed ID: 19245699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of RNA editing and ADARs on miRNA biogenesis and function.
    Heale BS; Keegan LP; O'Connell MA
    Adv Exp Med Biol; 2010; 700():76-84. PubMed ID: 21627032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered adenosine-to-inosine RNA editing in human cancer.
    Paz N; Levanon EY; Amariglio N; Heimberger AB; Ram Z; Constantini S; Barbash ZS; Adamsky K; Safran M; Hirschberg A; Krupsky M; Ben-Dov I; Cazacu S; Mikkelsen T; Brodie C; Eisenberg E; Rechavi G
    Genome Res; 2007 Nov; 17(11):1586-95. PubMed ID: 17908822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered RNA editing in 3' UTR perturbs microRNA-mediated regulation of oncogenes and tumor-suppressors.
    Zhang L; Yang CS; Varelas X; Monti S
    Sci Rep; 2016 Mar; 6():23226. PubMed ID: 26980570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer.
    Qi L; Song Y; Chan THM; Yang H; Lin CH; Tay DJT; Hong H; Tang SJ; Tan KT; Huang XX; Lin JS; Ng VHE; Maury JJP; Tenen DG; Chen L
    Nucleic Acids Res; 2017 Oct; 45(18):10436-10451. PubMed ID: 28985428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A-to-I miR-378a-3p editing can prevent melanoma progression via regulation of PARVA expression.
    Velazquez-Torres G; Shoshan E; Ivan C; Huang L; Fuentes-Mattei E; Paret H; Kim SJ; Rodriguez-Aguayo C; Xie V; Brooks D; Jones SJM; Robertson AG; Calin G; Lopez-Berenstein G; Sood A; Bar-Eli M
    Nat Commun; 2018 Jan; 9(1):461. PubMed ID: 29386624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypothesis: RNA editing of microRNA target sites in humans?
    Liang H; Landweber LF
    RNA; 2007 Apr; 13(4):463-7. PubMed ID: 17255198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A-to-I editing of microRNAs in the mammalian brain increases during development.
    Ekdahl Y; Farahani HS; Behm M; Lagergren J; Öhman M
    Genome Res; 2012 Aug; 22(8):1477-87. PubMed ID: 22645261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A mixed antagonistic/synergistic miRNA repression model enables accurate predictions of multi-input miRNA sensor activity.
    Gam JJ; Babb J; Weiss R
    Nat Commun; 2018 Jun; 9(1):2430. PubMed ID: 29934631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A-to-I editing in the miRNA seed region regulates target mRNA selection and silencing efficiency.
    Kume H; Hino K; Galipon J; Ui-Tei K
    Nucleic Acids Res; 2014 Sep; 42(15):10050-60. PubMed ID: 25056317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reprogramming of microRNAs by adenosine-to-inosine editing and the selective elimination of edited microRNA precursors in mouse oocytes and preimplantation embryos.
    García-López J; Hourcade Jde D; Del Mazo J
    Nucleic Acids Res; 2013 May; 41(10):5483-93. PubMed ID: 23571754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissecting the biological relationship between TCGA miRNA and mRNA sequencing data using MMiRNA-Viewer.
    Bai Y; Ding L; Baker S; Bai JM; Rath E; Jiang F; Wu J; Jiang H; Stuart G
    BMC Bioinformatics; 2016 Oct; 17(Suppl 13):336. PubMed ID: 27766936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A-to-I editing in human miRNAs is enriched in seed sequence, influenced by sequence contexts and significantly hypoedited in glioblastoma multiforme.
    Paul D; Sinha AN; Ray A; Lal M; Nayak S; Sharma A; Mehani B; Mukherjee D; Laddha SV; Suri A; Sarkar C; Mukhopadhyay A
    Sci Rep; 2017 May; 7(1):2466. PubMed ID: 28550310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenosine deaminases that act on RNA induce reproducible changes in abundance and sequence of embryonic miRNAs.
    Vesely C; Tauber S; Sedlazeck FJ; von Haeseler A; Jantsch MF
    Genome Res; 2012 Aug; 22(8):1468-76. PubMed ID: 22310477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Large-scale prediction of ADAR-mediated effective human A-to-I RNA editing.
    Yao L; Wang H; Song Y; Dai Z; Yu H; Yin M; Wang D; Yang X; Wang J; Wang T; Cao N; Zhu J; Shen X; Song G; Zhao Y
    Brief Bioinform; 2019 Jan; 20(1):102-109. PubMed ID: 28968662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of miRNA processing and miRNA mediated gene repression in cancer.
    Bajan S; Hutvagner G
    Microrna; 2014; 3(1):10-7. PubMed ID: 25069508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Base-pairing probability in the microRNA stem region affects the binding and editing specificity of human A-to-I editing enzymes ADAR1-p110 and ADAR2.
    Ishiguro S; Galipon J; Ishii R; Suzuki Y; Kondo S; Okada-Hatakeyama M; Tomita M; Ui-Tei K
    RNA Biol; 2018; 15(7):976-989. PubMed ID: 29950133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perturbation of biogenesis and targeting of Epstein-Barr virus-encoded miR-BART3 microRNA by adenosine-to-inosine editing.
    Lei T; Yuen KS; Tsao SW; Chen H; Kok KH; Jin DY
    J Gen Virol; 2013 Dec; 94(Pt 12):2739-2744. PubMed ID: 24045110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miRNA Editing: New Insights into the Fast Control of Gene Expression in Health and Disease.
    Mingardi J; Musazzi L; De Petro G; Barbon A
    Mol Neurobiol; 2018 Oct; 55(10):7717-7727. PubMed ID: 29460265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deciphering miRNAs' Action through miRNA Editing.
    Correia de Sousa M; Gjorgjieva M; Dolicka D; Sobolewski C; Foti M
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.